Health Care & Life Sciences » Biotechnology | International Stem Cell Corp.

International Stem Cell Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
10,479.00
12,478.00
2,635.00
1,079.00
6,069.00
2,131
Depreciation, Depletion & Amortization
464.00
458.00
472.00
331.00
326.00
308
Other Funds
5,058.00
5,269.00
1,164.00
2,782.00
3,867.00
953
Funds from Operations
4,957.00
6,751.00
3,327.00
3,530.00
1,876.00
870
Changes in Working Capital
681.00
336.00
843.00
667.00
266.00
212
Net Operating Cash Flow
5,638.00
6,415.00
4,170.00
4,197.00
2,142.00
1,082
Capital Expenditures
896.00
988.00
738.00
944.00
864.00
Sale of Fixed Assets & Businesses
-
1.00
-
1.00
-
Net Investing Cash Flow
896.00
987.00
738.00
943.00
864.00
Issuance/Reduction of Debt, Net
-
-
3,110.00
700.00
2,700.00
Net Financing Cash Flow
8,123.00
6,270.00
4,279.00
4,718.00
3,200.00
Net Change in Cash
1,589.00
1,132.00
629.00
422.00
194.00
Free Cash Flow
5,805.00
6,705.00
4,205.00
4,428.00
2,254.00
Change in Capital Stock
8,123.00
6,270.00
1,169.00
4,018.00
500.00

About International Stem Cell

View Profile
Address
5950 Priestly Drive
Carlsbad California 92008
United States
Employees -
Website http://www.internationalstemcell.com
Updated 07/08/2019
International Stem Cell Corp. is a biotechnology company, which in the development of biomedical products. It operates through the following segments: Cosmetic Market; Biomedical Market; and Therapeutic Market. The Cosmetic Market segment focuses in the skincare producs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.